Post job

Aridis Pharmaceuticals overview

Industry
Pharmaceutical
Revenue
Headquarters
Employees
33
Founded in
Website
Organization type
Public
Social media
Aridis is a private late-stage biopharmaceutical company focused on the discovery and development of targeted immunotherapy using fully human monoclonal antibodies, or mAbs, to treat life-threatening infections. mAbs represent an innovative treatment approach that harnesses the human immune system to fight infections and are designed to overcome the deficiencies associated with current therapies, such as rise in drug resistance, short duration of response, negative impact on the human microbiome, and lack of differentiation among the treatment alternatives. Aridis' product pipeline includes AR-101, a fully human immunoglobulin M mAb targeting P. aeruginosa serotype O11; AR-301, a fully human immunoglobulin 1, or IgG1, mAb targeting hospital-acquired pneumonia, or HAP, and ventilator-associated pneumonia, or VAP, S. aureus alphatoxin; AR-105, a fully human IgG1 mAb being developed to treat acute pneumonia caused by P. aeruginosa infection; AR-501, a broad spectrum small molecule anti-infective being developed to manage both chronic lung infections in cystic fibrosis patients and acute pneumonia in HAP and VAP patients; AR-401, our mAb discovery program aimed at treating infections caused by Acinetobacter baumannii.; and AR-201, a fully human IgG1 mAb that neutralizes diverse clinical isolates of respiratory syncytial virus, or RSV.
Based in San Jose, CA, Aridis Pharmaceuticals is a small pharmaceutical company with only 33 employees and an annual revenue of $1.0M.

Aridis Pharmaceuticals's mission statement

To deliver powerful, innovative anti-infective tools by demonstrating the clinical efficacy of AR-301 and AR-101 and seeking regulatory approvals as efficiently as possible.

In demand companies are hiring! Let Zippia apply for you!

Floating question marks illustration
-

Aridis Pharmaceuticals employee reviews

Be the first to review!

Do you work at Aridis Pharmaceuticals?

Help job seekers learn about working at Aridis Pharmaceuticals

On this page

Be the first to review Aridis Pharmaceuticals

Anonymously rate your employee experience

Your opinion can help other job seekers

Do you like working at Aridis Pharmaceuticals?

The team at Aridis Pharmaceuticals

  • The founders of Aridis Pharmaceuticals are Vu L. Truong and Eric J. Patzer.
  • The key people at Aridis Pharmaceuticals are Vu L. Truong and Eric J. Patzer.
Key people
Vu L. Truong
Eric J. Patzer

Aridis Pharmaceuticals rankings

Aridis Pharmaceuticals is ranked #7 on the Best Pharmaceutical companies to work for in San Jose, CA list. Zippia's Best Places to Work lists provide unbiased, data-based evaluations of companies. Rankings are based on government and proprietary data on salaries, company financial health, and employee diversity.

Read more about how we rank companies.

Rate Aridis Pharmaceuticals' promotion and raise policies.

Zippia waving zebra

Do you work at Aridis Pharmaceuticals?

Does Aridis Pharmaceuticals actively promote diversity and inclusion?

Aridis Pharmaceuticals financial performance

6.1
Performance score

Are you an executive, HR leader, or brand manager at Aridis Pharmaceuticals?

Claiming and updating your company profile on Zippia is free and easy.

Aridis Pharmaceuticals FAQs

Search for jobs

Zippia gives an in-depth look into the details of Aridis Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Aridis Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Aridis Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Aridis Pharmaceuticals. The data presented on this page does not represent the view of Aridis Pharmaceuticals and its employees or that of Zippia.

Aridis Pharmaceuticals may also be known as or be related to ARIDIS PHARM, ARIDIS PHARMACEUTICALS, INC., Aridis Pharmaceuticals, Aridis Pharmaceuticals Inc. and Aridis Pharmaceuticals, Inc.